ARDT

Ardent Health, Inc.

13.31 USD
+0.49
3.82%
At close Updated Sep 18, 4:00 PM EDT
Pre-market
After hours
13.31
0.00
0%
1 day
3.82%
5 days
1.22%
1 month
5.47%
3 months
2.7%
6 months
-6.66%
Year to date
-21.01%
1 year
-22.07%
5 years
-17.12%
10 years
-17.12%
 

About: Ardent Health Inc is a provider of healthcare in growing mid-sized urban communities across the U.S. With a focus on people and investments in services and technologies, Ardent is passionate about making healthcare easier to access.

Employees: 24,900

0
Funds holding %
of 7,463 funds
0
Analysts bullish %
of 4 analysts

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

29,420% more call options, than puts

Call options by funds: $1.48M | Put options by funds: $5K

55% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 31

5% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 19

1% more funds holding

Funds holding: 108 [Q1] → 109 (+1) [Q2]

0.36% more ownership

Funds ownership: 66.14% [Q1] → 66.5% (+0.36%) [Q2]

0% more funds holding in top 10

Funds holding in top 10: 1 [Q1] → 1 (+0) [Q2]

0% less capital invested

Capital invested by funds: $1.3B [Q1] → $1.3B (-$510K) [Q2]

Research analyst outlook

4 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$14.6
10% upside
Avg. target
$16.65
25% upside
High target
$20
50% upside

4 analyst ratings

positive
50%
neutral
25%
negative
25%
UBS
A.J. Rice
$17
Buy
Initiated
10 Sep 2025
JP Morgan
Benjamin Rossi
$15
Neutral
Maintained
11 Aug 2025
Keybanc
Matthew Gillmor
$20
Overweight
Maintained
7 Aug 2025
B of A Securities
Kevin Fischbeck
$14.6
Underperform
Downgraded
16 Jul 2025

Financial journalist opinion

Neutral
Seeking Alpha
10 days ago
Ardent Health, Inc. (ARDT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
Ardent Health, Inc. (NYSE:ARDT ) Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025 7:45 AM EDT Company Participants Martin Bonick - President, CEO & Director Alfred Lumsdaine - Chief Financial Officer Conference Call Participants Craig Hettenbach - Morgan Stanley, Research Division Presentation Craig Hettenbach VP & Equity Analyst All right. Great. Good morning, everyone.
Ardent Health, Inc. (ARDT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
Neutral
Business Wire
24 days ago
Ardent Health to Participate in September Investor Conferences
BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health to participate in September investor conferences.
Ardent Health to Participate in September Investor Conferences
Positive
The Motley Fool
1 month ago
Ardent Health (ARDT) Q2 EPS Jumps 126%
Ardent Health (ARDT) Q2 EPS Jumps 126%
Ardent Health (ARDT) Q2 EPS Jumps 126%
Neutral
The Motley Fool
1 month ago
Ardent Health (ARDT) Q2 2025 Earnings Transcript
Image source: The Motley Fool.
Ardent Health (ARDT) Q2 2025 Earnings Transcript
Positive
Zacks Investment Research
1 month ago
Ardent Health, Inc. (ARDT) Q2 Earnings and Revenues Surpass Estimates
Ardent Health, Inc. (ARDT) came out with quarterly earnings of $0.52 per share, beating the Zacks Consensus Estimate of $0.3 per share. This compares to earnings of $0.35 per share a year ago.
Ardent Health, Inc. (ARDT) Q2 Earnings and Revenues Surpass Estimates
Neutral
Business Wire
1 month ago
Ardent Health Reports Second Quarter 2025 Results
BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health, Inc. (NYSE: ARDT) ("Ardent Health" or the "Company"), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced results for the quarter ended June 30, 2025. Second Quarter 2025 Operating and Financial Summary All comparisons are versus the same prior year period. See the footnotes to the Operating Statistics table of this press release for definitions of the metrics below and a full list of key oper.
Ardent Health Reports Second Quarter 2025 Results
Negative
Zacks Investment Research
1 month ago
Analysts Estimate Ardent Health, Inc. (ARDT) to Report a Decline in Earnings: What to Look Out for
Ardent Health, Inc. (ARDT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Ardent Health, Inc. (ARDT) to Report a Decline in Earnings: What to Look Out for
Positive
MarketBeat
1 month ago
Falling Fast, Rising Soon? 3 Stocks With Upside Ahead
Volatility can present an opportunity to buy compelling securities at a comparably low price, provided that an investor is willing to take on a certain degree of risk. Of course, it's not a guarantee that a company with a falling share price will reverse course and yield returns, but investors set themselves up with better chances of success when they identify strong candidates.
Falling Fast, Rising Soon? 3 Stocks With Upside Ahead
Neutral
Business Wire
1 month ago
Ardent Health Announces Second Quarter 2025 Results Conference Call and Webcast Date
BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that it will issue its second quarter 2025 results after the market closes on Tuesday, August 5, 2025. A conference call will be held the following day, Wednesday, August 6, 2025, at 10 a.m. ET to review the company's financial results, discuss recent events and conduct a question-and-answer session. A webcast of the conference c.
Ardent Health Announces Second Quarter 2025 Results Conference Call and Webcast Date
Negative
Seeking Alpha
2 months ago
Ardent Health: The Best Prospect In An Industry That's Facing Challenges
Ardent Health faces significant legislative risks, due to Medicaid and Medicare cuts, causing uncertainty and a recent downgrade, but much of this is priced in. Despite headwinds, Ardent Health demonstrates strong revenue and profitability growth, low leverage, and trades at compellingly cheap valuations, versus peers. Management projects continued growth for 2025, with revenue and EBITDA expected to rise, supported by higher-margin service expansions and acquisitions.
Ardent Health: The Best Prospect In An Industry That's Facing Challenges
Charts implemented using Lightweight Charts™